Legion logo
Sign in

Cityblock Health

CH
AIBrooklynFounded 2017Website@cityblockhealth
#376 by valuationHype63

Cityblock Health is a tech-driven provider for communities with complex needs it focuses on investing upstream in highly personalized, prevention-oriented health and social care to ultimately drive down costs and improve outcomes. Its technology enables scale by bringing together practical information, coordination, and communication for its members and care teams. During COVID-19, Cityblock created a model to help organizations determine which of their members are at high risk of COVID-19.

Founded by Toyin Ajayi (Co-founder & CEO), Iyah Romm (Co-founder, founding CEO), Bay Gross (Co-founder, former Chief Product Officer)

Blended valuation$2.2B$1.9B secondary
Valuation history
Weekly blended valuation with priced funding rounds marked on the timeline.
$7.1B
blended valuationfunding round
May 31, 2021$531.9MOct 5, 2026
All rounds
9 funding rounds, newest first.
RoundAnnouncedRaisedPost-money
Series EAug 20, 2026$116M$2.4B
Series XJun 18, 2024$39M$1.6B
Series DSep 3, 2021$400M$5.7B
Series CMar 29, 2021$192M$3B
Series CDec 10, 2020$160M$1B
Join Legion to view all 9 rounds.Sign in to Legion
Investors
30 investors across all rounds.
  • MV
    Maverick Ventures
  • RE
    Redpoint
  • GC
    General Catalyst
  • KI
    Kinnevik
  • SV
    SoftBank Vision Fund
  • TG
    Tiger Global Management
  • TC
    Thrive Capital
  • 8V
    8VC
  • EH
    Echo Health Ventures
  • GS
    Goldman Sachs
Only Legion members can view the full investor roster. Sign in to Legion
Secondary market activity
Recent buy and sell interest for Cityblock Health shares on the secondary market.
KindImplied valuationPrice / shareDate
Quote$1.6B$19.95Sep 29, 2026
Quote$1.6B$78.86Sep 29, 2026
Quote$1.7B$21.50Sep 12, 2026

Invest in the private markets on Legion

Registered users see full trading activity, every investor, rankings, and live deals.

Get started

Data as of Oct 16, 2026. Valuations are estimates blended from primary and secondary-market signals — not investment advice.